Financial statements Novartis Poland
Balance sheet data of NOVARTIS POLAND
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 177 893 084,90 | 189 842 443,57 | 189 808 262,17 | 187 701 951,91 | 232 544 607,32 | 301 067 063,50 |
| A. Fixed assets | 5 676 320,51 | 6 161 246,00 | 8 485 291,15 | 15 251 245,78 | 14 961 341,44 | 17 151 797,26 |
| B. Current assets | 172 216 764,39 | 183 681 197,57 | 181 322 971,02 | 172 450 706,13 | 217 583 265,88 | 283 915 266,24 |
| C. Share capital contributions (basic funds) | - | - | - | - | 0,00 | 0,00 |
| D. Own shares (stocks) | - | - | - | - | 0,00 | 0,00 |
| Total liabilities | 177 893 084,90 | 189 842 443,57 | 189 808 262,17 | 187 701 951,91 | 232 544 607,32 | 301 067 063,50 |
| A. Equity | 99 868 519,29 | 107 113 600,90 | 113 099 279,15 | 121 622 800,00 | 135 625 173,05 | 151 167 734,79 |
| B. Liabilities and provisions for liabilities | 78 024 565,61 | 82 728 842,67 | 76 708 983,02 | 66 079 151,91 | 96 919 434,27 | 149 899 328,71 |
| I. Long-term liabilities | - | - | - | - | 0,00 | 0,00 |
| II. Short-term liabilities | 60 976 847,78 | 60 006 939,17 | 58 552 413,15 | 40 459 239,36 | 62 118 728,56 | 124 708 729,97 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.